Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue

American Journal of Respiratory Cell and Molecular Biology

Volumn 28, Issue 4, 2003, Pages 464-472

  Frevert, Charles W ^a   Kinsella, Michael G ^b   Vathanaprida, Charie ^b   Goodman, Richard B ^b   Baskin, Denis G ^b   Proudfoot, Amanda ^b   Wells, Timothy N C ^b   Wight, Thomas N ^b   Martin, Thomas R ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; INTERLEUKIN 8;

ARTICLE; BINDING ASSAY; CELL SURFACE; CONFOCAL MICROSCOPY; DIMERIZATION; EXTRACELLULAR MATRIX; IMMUNOLOCALIZATION; LUNG PARENCHYMA; MUTATION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN INTERACTION;

CHONDROITIN SULFATES; HEPARITIN SULFATE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; LUNG; MICROSCOPY, CONFOCAL; PROTEIN BINDING;

EID: 0037383980     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2002-0084OC     Document Type: Article

References (50)

1. Rollins, B. J. 1997. Chemokines. Blood 90:909-928.
2. Zlotnik, A., and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12:121-127.
3. Abul, H., A. Abul, I. Khan, T. C. Mathew, A. Ayed, and E. Al-Athary. 2001. Levels of IL-8 and myeloperoxidase in the lungs of pneumonia patients Mol. Cell Biochem. 217:107-112.
4. Miller, E. J., A. B. Cohen, S. Nagao, D. Griffith, R. J. Maunder, T. R. Martin, J. P. Weiner-Kronish, M. Sticherling, E. Christophers, and M. A. Matthay. 1992. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am. Rev. Respir. Dis. 146:427-432.
5. Baughman, R. P., K. L. Gunther, M. C. Rashkin, D. A. Keeton, and E. N. Pattishall. 1996. Changes in the inflammatory response of the lung during acute respiratory distress syndrome: prognostic indicators. Am. J. Respir. Crit. Care Med. 154:76-81.
6. Miller, E. J., A. B. Cohen, and M. A. Matthay. 1996. Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis. Crit. Care Med. 24:1448-1454.
7. Goodman, R. B., R. M. Strieter, D. P. Martin, K. P. Steinberg, J. A. Milberg, R. J. Maunder, S. L. Kunkel, A. Walz, L. D. Hudson, and T. R. Martin. 1996. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154:602-611.
8. Lee, J., R. Horuk, G. C. Rice, G. L. Bennett, T. Camerato, and W. I. Wood. 1992. Characterization of two high affinity human interleukin-8 receptors J. Biol. Chem. 267:16283-16287.
9. Hoogewerf, A. J., G. S. Kuschert, A. E. Proudfoot, F. Borlat, I. Clark-Lewis, C. A. Power, and T. N. Wells, 1997. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36:13570-13578.
10. Kuschert, G. S., A. J. Hoogewerf, A. E. Proudfoot, C. W. Chung, R. M. Cooke, R. E. Hubbard, T. N. Wells, and P. N. Sanderson. 1998. Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry 37:11193-11201.
11. Hebert, C. A., R. V. Vitangcol, and J. B. Baker. 1991. Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J. Biol. Chem. 266:18989-18994.
12. Clark-Lewis, I., C. Schumacher, M. Baggiolini, and B. Moser. 1991. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs: critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. J. Biol. Chem. 266:23128-23134.
13. Kuschert, G. S., F. Coulin, C. A. Power, A. E. Proudfoot, R. E. Hubbard, A. J. Hoogewerf, and T. N. Wells. 1999. Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38:12959-12968.
14. Burrows, S. D., M. L. Doyle, K. P. Murphy, S. G. Franklin, J. R. White, I. Brooks, D. E. McNulty, M. O. Scott, J. R. Knutson, D. Porter, P. R. Young, and P. Hensley. 1994. Determination of the monomer-dimer equilibrium of interleukin-8 reveals it is a monomer at physiological concentrations Biochemistry 33:12741-12745.
15. Lowman, H. B., W. J. Fairbrother, P. H. Slagle, R. Kabakoff, J. Liu, S. Shire, and C. A. Hebert. 1997. Monomeric variants of IL-8: effects of side chain substitutions and solution conditions upon dimer formation. Protein Sci. 6:598-608.
16. Paolini, J. F., D. Willard, T. Consler, M. Luther, and M. S. Krangel. 1994. The chemokines IL-8, monocyte chemoattractant protein-1, and I-309 are monomers at physiologically relevant concentrations. J. Immunol. 153:2704-2717.
17. Rajarathnam, K., B. D. Sykes, C. M. Kay, B. Dewald, T. Geiser, M. Baggiolini, and I. Clark-Lewis. 1994. Neutrophil activation by monomeric interleukin-8. Science 264:90-92.
18. Horcher, M., A. Rot, H. Aschauer, and J. Besemer. 1998. IL-8 derivatives with a reduced potential to form homodimers are fully active in vitro and in vivo. Cytokine 10:1-12.
19. Frevert, C. W., R. B. Goodman, M. G. Kinsella, O. Kajikawa, K. Ballman, I. Clark-Lewis, A. E. Proudfoot, T. N. Wells, and T. R. Martin. 2002. Tissue-specific mechanisms control the retention of IL-8 in lungs and skin. J. Immunol. 168:3550-3556.
20. Webb, L. M., M. U. Ehrengruber, L. I. Clark, M. Baggiolini, and A. Rot. 1993. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc. Natl. Acad. Sci. USA 90:7158-7162.
21. Middleton, J., S. Neil, J. Wintle, L.-I. Clark, H. Moore, C. Lam, M. Auer, E. Hub, and A. Rot. 1997. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91:385-395.
22. Rot, A. 1992. Binding of neutrophil attractant/activation protein-1 (interleukin 8) to resident dermal cells. Cytokine 4:347-352.
23. Rot, A. 1992. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol. Today 13:291-294.
24. Rot, A. 1993. Neutrophil attractant/activation protein-1 (interleukin-8) induces in vitro neutrophil migration by haptotactic mechanism. Eur. J. Immunol. 23:303-306.
25. Rot, A., E. Hub, J. Middleton, F. Pons, C. Rabeck, K. Thierer, J. Wintle, B. Wolff, M. Zsak, and P. Cukor. 1996. Some aspects of IL-8 pathophysiology III: chemokine interaction with endothelial cells. J. Leukoc. Biol. 59:39-44.
26. Wight, T. N., D. K. Heinegard, and V. C. Hascall. 1991. Proteoglycans: structure and function. In E. Hay, editor. Cell Biology of the Extracellular Matrix, 2nd ed. Plenum Press, New York. 45-77.
27. Sampson, P. M., R. B. Boyd, G. G. Pietra, and A. P. Fishman. 1984. Glycosaminoglycan biosynthesis in the isolated perfused rat lung. J. Appl. Physiol 57:1648-1654.
28. Spillmann, D., D. Witt, and U. Lindahl. 1998. Defining the interleukin-8-binding domain of heparan sulfate. J. Biol. Chem. 273:15487-15493.
29. Roberts, C. R., T. N. Wight, and V. C. Hascall. 1997. Proteoglycans. In R. Crystal, J. West, E. Weibel. and P. Barnes, editors The Lung: Scientific Foundations, 2nd ed, Lippinocott-Raven Press, Philadelphia. 757-767.
30. Kure, S., and O. Yoshie. 1986. A syngeneic monoclonal antibody to murine Meth-A sarcoma (HepSS-1) recognizes heparan sulfate glycosaminoglycan (HS-GAG): cell density and transformation dependent alteration in cell surface HS-GAG defined by HepSS-1. J. Immunol. 137:3900-3908.
31. Avnur, Z., and B. Geiger, 1984. Immunocytochemical localization of native chondroitin-sulfate in tissues and cultured cells using specific monoclonal antibody. Cell 38:811-822.
32. Baskin, D. G. 1993. Quantitative analysis of radioligand binding autoradiographs In J. Wharton and J. Polak, editors. Receptor Autoradiography: Principles and Practice. Oxford University Press, New York. 107-130.
33. Snow, A. D., R. Bramson, H. Mar, T. N. Wight, and R. Kisilevsky. 1991. A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. J. Histochem. Cytochem. 39:1321-1330.
34. Allen, B. L., M. S. Filla, and A. C. Rapraeger. 2001. Role of heparan sulfate as a tissue-specific regulator of FGF-4 and FGF receptor recognition. J. Cell Biol. 155:845-858.
35. van Kuppevelt, T. H., F. P. Cremers, J. G. Domen, and C. M. Kuyper. 1984. Staining of proteoglycans in mouse lung alveoli: II. Characterization of the Cuprolinic blue-positive, anionic sites. Histochem. J. 16:671-686.
36. Kajikawa, O., R. B. Goodman, M. C. Johnson, K. Konishi, and T. R. Martin. 1996. Sensitive and specific immunoassays to detect rabbit IL-8 and MCP-1 cytokines that mediate leukocyte recruitment to the lungs. J. Immunol. Meth. 197:19-29.
37. Horwitz, A. L., and R. C. Crystal. 1975. Content and synthesis of glycosaminoglycans in the developing lung. J. Clin. Invest. 56:1312-1318.
38. Tanaka, Y., D. Adams, S. Hubscher, H. Hirano, U. Siebenlist, and S. Shaw. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 361:79-82.
39. McCormick, B. A., P. M. Hofman, J. Kim, D. K. Carnes, S. I. Miller, and J. L. Madara. 1995. Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils. J. Cell Biol. 131:1599-1608.
40. Netelenbos, T., S. Zuijderduijn, J. Van Den Born, F. L. Kessler, S. Zweegman, P. C. Huijgens, and A. M. Drager. 2002. Proteoglycans guide SDF-1-induced migration of hematopoietic progenitor cells. J. Leukoc. Biol. 72:353-362
41. Clark-Lewis, I., K. S. Kim, K. Rajarathnam, J. H. Gong, B. Dewald, B. Moser, M. Baggiolini, and B. D. Sykes. 1995. Structure-activity relationships of chemokines. J. Leukoc. Biol. 57:703-711.
42. Gospodarowicz, D., and J. Cheng. 1986. Heparin protects basic and acidic FGF from inactivation. J. Cell. Physiol. 128:475-484.
43. Saksela, O., D. Moscatelli, A. Sommer, and D. B. Rifkin. 1988. Endothelial cell-derive heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J. Cell Biol. 107:743-751.
44. Blackwood, R. A., J. O. Cantor, J. Moret, I. Mandl, and G. M. Turino. 1983. Glycosaminoglycan synthesis in endotoxin-induced lung injury. Proc. Soc. Exp. Biol. Med. 174:343-349.
45. Karlinsky, J. B., and R. H. Goldstein. 1989. Regulation of sulfated glycosaminoglycan production by prostaglandin E2 in cultured lung fibroblasts. J. Lab. Clin. Med. 114:176-184.
46. Karlinsky, J. B., P. J. Bucay, D. E. Ciccolella, and M. P. Crowley. 1991. Effects of intratracheal endotoxin administration on hamster lung glycosaminoglycans. Am. J. Physiol. 261:L148-L155.
47. Bensadoun, E. S., A. K. Burke, J. C. Hogg, and C. R. Roberts. 1996. Proteoglycan deposition in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 154:1819-1828.
48. Bensadoun, E. S., A. K. Burke, J. C. Hogg, and C. R. Roberts. 1997. Proteoglycans in granulomatous lung diseases. Eur. Respir. J. 10:2731-2737.
49. Venkatesan, N., T. Ebihara, P. J. Roughley, and M. S. Ludwig. 2000. Alterations in large and small proteoglycans in bleomyein-induced pulmonary fibrosis in rats. Am. J Respir. Crit. Care Med. 161:2066-2073.
50. Hirose, J., H. Kawashima, O. Yoshie, K. Tashiro, and M. Miyasaka. 2001. Versican interacts with chemokines and modulates cellular responses. J. Biol. Chem. 276:5228-5234.